- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.03. | Prenetics Global Limited: Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market | 2 | GlobeNewswire (USA) | ||
| 05.03. | Prenetics Global reports Q4 results | 1 | Seeking Alpha | ||
| 05.03. | Prenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance | 113 | GlobeNewswire (Europe) | Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first... ► Artikel lesen | |
| 05.03. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.02. | Prenetics Global Limited: Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve | 1 | GlobeNewswire (USA) | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 15.01. | Prenetics Global Limited: Prenetics' IM8 Achieves Prestigious NSF Certified for Sport for Daily Ultimate Essentials | 1 | GlobeNewswire (USA) | ||
| 13.12.24 | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.12.24 | Prenetics Global Limited: Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services | 1 | GlobeNewswire (USA) | ||
| 27.11.24 | Prenetics Global Q3 Loss Narrows On Surge In Revenue | - | RTTNews | ||
| 27.11.24 | Prenetics Global: Q3 Earnings Insights | 1 | Benzinga.com | ||
| 27.11.24 | Prenetics Global Limited: Prenetics Announces Third Quarter 2024 Financial Results | 368 | GlobeNewswire (Europe) | Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta's Early Cancer... ► Artikel lesen | |
| 27.11.24 | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.11.24 | Prenetics Global Limited: Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health | 2 | GlobeNewswire (USA) | ||
| 15.10.24 | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.10.24 | Prenetics Global GAAP EPS of -$1.58, revenue of $5.9M | 4 | Seeking Alpha | ||
| 07.10.24 | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.10.24 | Prenetics Global Limited: Prenetics Announces Second Quarter 2024 Financial Results | 462 | GlobeNewswire (Europe) | Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024Enters U.S. Health Market in October with IM8, a New Health and Wellness BrandRe-affirms Revenue Target to Exceed US$33 million for FY... ► Artikel lesen | |
| 11.07.24 | Prenetics Global Limited: Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham | 458 | GlobeNewswire (Europe) | Beckham becomes a strategic investor in PreneticsBeckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics... ► Artikel lesen | |
| 18.06.24 | Prenetics Global Limited: Prenetics Announces First Quarter 2024 Financial Results | 219 | GlobeNewswire (Europe) | First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range... ► Artikel lesen | |
| 01.04.24 | Prenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results | 277 | GlobeNewswire (Europe) | HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QUANTUM-SI | 1,195 | 0,00 % | Quantum-Si begins global shipment of Platinum Pro sequencer | ||
| SCILEX | 0,238 | 0,00 % | Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva | PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, "Scilex" or "Company"), an innovative revenue-generating company focused on acquiring, developing and commercializing... ► Artikel lesen | |
| TEMPUS AI | 48,240 | 0,00 % | Why Tempus AI Inc. (TEM) Crashed On Wednesday? | ||
| PRAXIS PRECISION MEDICINES | 37,870 | 0,00 % | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | |
| DYNE THERAPEUTICS | 10,460 | 0,00 % | Dyne Therapeutics (NASDAQ:DYN) Trading 5.4% Higher - What's Next? | ||
| QIAGEN | 37,310 | +1,73 % | Biotech Report: Sektor unter Druck - Evotec verlieren, Qiagen behauptet | (shareribs.com) Frankfurt / New York 26.03.2025 - Biotechwerte tendierten im deutschen Handel schwächer, lediglich 4SC konnte leichte Kursgewinne verbuchen. An der Wall Street rutschte der Sektor ab.... ► Artikel lesen | |
| BEAM THERAPEUTICS | 19,545 | 0,00 % | Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) by the United States (U.S.) Food and Drug Administration | U.S. IND Represents Regulatory Clearance For BEAM-302 Spanning Six Countries and Second Open IND for a Beam In Vivo Base Editing Program in the U.S. CAMBRIDGE, Mass., March 27, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,285 | 0,00 % | Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today | ||
| ADMA BIOLOGICS | 19,820 | 0,00 % | How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback | ||
| SPRINGWORKS THERAPEUTICS | 44,150 | 0,00 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates | - Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively - - Received FDA approval of GOMEKLI (mirdametinib)... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 29,510 | 0,00 % | Avidity Biosciences Inc Aktie: Neue Marktbedingungen, was bedeutet das? | Avidity Biosciences verzeichnete am Freitag einen Kursrückgang von 2,95 Prozent auf 31,60 USD. Trotz dieser kurzfristigen Schwäche konnte das Unternehmen im Monatsvergleich ein Plus von 7,67 Prozent... ► Artikel lesen | |
| NUVALENT | 70,88 | 0,00 % | Nuvalent-Entwicklungschefin verkauft Aktien im Wert von 292.468 US-Dollar | ||
| IMMUNOVANT | 17,080 | 0,00 % | Immunovant Inc.: Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies | Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the higher dose arm (with 74% mean IgG reduction) and a... ► Artikel lesen | |
| VERA THERAPEUTICS | 24,020 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement awards consisting of... ► Artikel lesen | |
| ARVINAS | 7,010 | 0,00 % | Pre-market Movers: 2seventy bio, Sonoma Pharmaceuticals, Tenon Medical, Arvinas, NET Power Inc. | LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green 2seventy bio, Inc. (TSVT) is up over 76% at $4.93.
Sonoma... ► Artikel lesen |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 4,050 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.
